Succinimide

Succinimide

SCHEMBL31013191

O=C(O)Oc1ccccc1.O=C1CCC(=O)N1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 6/20 0.45
DDB1 Q16531 5/20 0.45
SMN1; SMN2 Q16637 1/20 0.41
NPC1 O15118 1/20 0.41
MAPK13 O15264 1/20 0.41
MAPK12 P53778 1/20 0.41
MAPK11 Q15759 1/20 0.41
MAPK14 Q16539 1/20 0.41
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HSP90AA1 P07900 1/20 0.41
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ATM Q13315 1/20 0.40
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ELANE P08246 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37064 0.81 TDP1 (0.54) MAPTTDP1KDM4EALDH1A1HSP90AA1
Cyclohexane SCHEMBL6263406 0.79 ALDH1A1 (0.53) SMN1; SMN2NPC1MAPTTDP1KDM4E
Bicarbonate SCHEMBL27833263 0.79 TDP1 (0.52) MAPTTDP1KDM4EALDH1A1HSP90AA1
Hydrochloric Acid SCHEMBL8603620 0.79 TDP1 (0.52) MAPTTDP1KDM4EALDH1A1HSP90AA1
SCHEMBL27415781 0.79 TDP1 (0.52) MAPTTDP1KDM4EALDH1A1HSP90AA1
Ammonia Solution, Strong SCHEMBL10392312 0.79 TDP1 (0.52) MAPTTDP1KDM4EALDH1A1HSP90AA1
SCHEMBL28228236 0.79 TDP1 (0.52) MAPTTDP1KDM4EALDH1A1HSP90AA1
Ammonia Solution, Strong SCHEMBL28972528 0.79 TDP1 (0.52) MAPTTDP1KDM4EALDH1A1HSP90AA1
SCHEMBL28599729 0.79 TDP1 (0.52) MAPTTDP1KDM4EALDH1A1HSP90AA1
SCHEMBL27412713 0.79 TDP1 (0.52) MAPTTDP1KDM4EALDH1A1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113045491-B Preparation method of lenvatinib and intermediate 罗欣药业(上海)有限公司 2024-09-06 CN disclosed